Ronald Marcus
CIK 1653237 · View on SEC EDGAR ↗
First SEC filing: Oct. 14, 2015 · Latest: Oct. 14, 2015
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 20, 2015 | AVTX | P | 13,693 | — | — | 36,000 Direct | +61.38% | Acquired | (price as of 2026-08-19) |
| Oct. 20, 2015 | AVTX | P | 13,693 | — | — | 36,000 Direct | +61.38% | Acquired | (price as of 2026-08-19) |
| Oct. 20, 2015 | AVTX | P | 16,924 | — | — | 22,307 Direct | +314.40% | Acquired | (price as of 2026-08-19) |
| Oct. 20, 2015 | AVTX | P | 16,924 | — | — | 22,307 Direct | +314.40% | Acquired | (price as of 2026-08-19) |
| Oct. 20, 2015 | AVTX | P | 13,693 | — | — | 36,000 Direct | +61.38% | Acquired | (price as of 2026-08-19) |
| Oct. 20, 2015 | AVTX | P | 16,924 | — | — | 22,307 Direct | +314.40% | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 17, 2016 | AVTX | Employee Stock Option (Right to Buy) | Common Stock (40,000) | $3.77 | Aug. 16, 2026 | 40,000 | Acquired |
| Feb. 24, 2016 | AVTX | Employee Stock Option (Right to Buy) | Common Stock (44,286) | $3.01 | Feb. 24, 2026 | 44,286 | Acquired |
| Oct. 20, 2015 | AVTX | Class B Warrant (Right to Buy) | Common Stock (6,846) | $3.90 | April 20, 2017 | 13,693 | Acquired |
| Oct. 20, 2015 | AVTX | Class A Warrant (Right to Buy) | Common Stock (13,693) | $4.55 | Oct. 20, 2018 | 13,693 | Acquired |
| Oct. 20, 2015 | AVTX | Class B Warrant (Right to Buy) | Common Stock (8,462) | $3.90 | April 20, 2017 | 16,924 | Acquired |
| Oct. 20, 2015 | AVTX | Class A Warrant (Right to Buy) | Common Stock (16,924) | $4.55 | Oct. 20, 2018 | 16,924 | Acquired |
| Oct. 20, 2015 | AVTX | Class B Warrant (Right to Buy) | Common Stock (2,692) | $3.90 | April 20, 2017 | 5,383 | Acquired |
| Oct. 20, 2015 | AVTX | Class A Warrant (Right to Buy) | Common Stock (5,383) | $4.55 | Oct. 20, 2018 | 5,383 | Acquired |
| Oct. 20, 2015 | AVTX | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $6.49 | Oct. 19, 2024 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 14, 2015 | AVTX | Stock Option (Right to Buy)→ Common Stock (55,714) | 55,714 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
AVTX
M.D.(5)Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $354,145 | — | — | — | — | — | $19,142 | $373,287 |
| 2016 | $356,200 | — | — | $200,925 | — | — | $24,000 | $581,125 |
| 2015 | $213,375 | $63,459 | — | $208,613 | — | — | $19,000 | $504,447 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.